Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

February 15, 1987; Volume 138,Issue 4

ARTICLES

  • You have accessRestricted access
    Expression and role of the T cell receptor in early thymocyte differentiation in vitro.
    W Born, M McDuffie, N Roehm, E Kushnir, J White, D Thorpe, J Stefano, J Kappler and P Marrack
    J Immunol February 15, 1987, 138 (4) 999-1008;
  • You have accessRestricted access
    Phenotypic identification of memory cytolytic T lymphocytes in a subset of Lyt-2+ cells.
    R C Budd, J C Cerottini and H R MacDonald
    J Immunol February 15, 1987, 138 (4) 1009-1013;
  • You have accessRestricted access
    Target cell recognition structures in LDCC and ODCC.
    K C Gorman, K P Kane and W R Clark
    J Immunol February 15, 1987, 138 (4) 1014-1019;
  • You have accessRestricted access
    Defective differentiation of natural killer cells in SJL mice. Role of the thymus.
    S G Kaminsky, V Milisauskas, P B Chen and I Nakamura
    J Immunol February 15, 1987, 138 (4) 1020-1025;
  • You have accessRestricted access
    Cell kinetics in the fetal mouse thymus: precursor cell input, proliferation, and emigration.
    F Jotereau, F Heuze, V Salomon-Vie and H Gascan
    J Immunol February 15, 1987, 138 (4) 1026-1030;
  • You have accessRestricted access
    Characterization of helper T cells induced by the type 2 antigen polyvinylpyrrolidone.
    A M Van Buskirk and H Braley-Mullen
    J Immunol February 15, 1987, 138 (4) 1031-1037;
  • You have accessRestricted access
    Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
    K Kosmatopoulos, D S Algara and S Orbach-Arbouys
    J Immunol February 15, 1987, 138 (4) 1038-1041;
  • You have accessRestricted access
    Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 origin.
    J Reimann, A Bellan and D Kabelitz
    J Immunol February 15, 1987, 138 (4) 1042-1050;
  • You have accessRestricted access
    The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.
    C A Janeway Jr, J Ron and M E Katz
    J Immunol February 15, 1987, 138 (4) 1051-1055;
  • You have accessRestricted access
    Effects of antigens and lymphokines on early activation of single hapten-specific B lymphocytes.
    M R Alderson, B L Pike and G J Nossal
    J Immunol February 15, 1987, 138 (4) 1056-1063;
  • You have accessRestricted access
    Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    A H Rook, H C Lane, T Folks, S McCoy, H Alter and A S Fauci
    J Immunol February 15, 1987, 138 (4) 1064-1067;
  • You have accessRestricted access
    Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    A B Tilden, K Itoh and C M Balch
    J Immunol February 15, 1987, 138 (4) 1068-1073;
  • You have accessRestricted access
    Inhibition of human B cell responsiveness by prostaglandin E2.
    N J Simkin, D F Jelinek and P E Lipsky
    J Immunol February 15, 1987, 138 (4) 1074-1081;
  • You have accessRestricted access
    A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis.
    L S Collins and K Dorshkind
    J Immunol February 15, 1987, 138 (4) 1082-1087;
  • You have accessRestricted access
    Class I-like MHC molecules expressed by baboon placental syncytiotrophoblast.
    P L Stern, N Beresford, C I Friedman, V C Stevens, J M Risk and P M Johnson
    J Immunol February 15, 1987, 138 (4) 1088-1091;
  • You have accessRestricted access
    Transfer of experimental autoimmune thyroiditis with T cell clones.
    C G Romball and W O Weigle
    J Immunol February 15, 1987, 138 (4) 1092-1098;
  • You have accessRestricted access
    Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3.
    H J Ziltener, I Clark-Lewis, L E Hood, S B Kent and J W Schrader
    J Immunol February 15, 1987, 138 (4) 1099-1104;
  • You have accessRestricted access
    Antipeptide antibodies define the NH2-terminal structure of the pan-specific hemopoietin interleukin 3.
    H J Ziltener, I Clark-Lewis, B Fazekas de St Groth, L E Hood, S B Kent and J W Schrader
    J Immunol February 15, 1987, 138 (4) 1105-1108;
  • You have accessRestricted access
    Expression in Escherichia coli of fully active recombinant human IL 1 beta: comparison with native human IL 1 beta.
    M J Tocci, N I Hutchinson, P M Cameron, K E Kirk, D J Norman, J Chin, E A Rupp, G A Limjuco, V M Bonilla-Argudo and J A Schmidt
    J Immunol February 15, 1987, 138 (4) 1109-1114;
  • You have accessRestricted access
    The cyclosporins inhibit lymphocyte activation at more than one site.
    E W Gelfand, R K Cheung and G B Mills
    J Immunol February 15, 1987, 138 (4) 1115-1120;
  • You have accessRestricted access
    Characterization of a novel murine T cell-activating factor.
    R D Garman and D H Raulet
    J Immunol February 15, 1987, 138 (4) 1121-1129;
  • You have accessRestricted access
    A quantitative analysis of antigen-triggered lymphokine production by activated T cells.
    R G Gill, S K Babcock and K J Lafferty
    J Immunol February 15, 1987, 138 (4) 1130-1136;
  • You have accessRestricted access
    Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells.
    Y Kubota, T A Gaither, J Cason, J J O'Shea and T J Lawley
    J Immunol February 15, 1987, 138 (4) 1137-1142;
  • You have accessRestricted access
    Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba.
    A Ueda, J F Kearney, K H Roux and J E Volanakis
    J Immunol February 15, 1987, 138 (4) 1143-1149;
  • You have accessRestricted access
    Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.
    D A Bobak, T A Gaither, M M Frank and A J Tenner
    J Immunol February 15, 1987, 138 (4) 1150-1156;
  • You have accessRestricted access
    Behavior of aldehyde moieties involved in the activation of suppressor cells by sodium periodate.
    S M Dehoux-Zenou, M Guenounou, H Zinbi, P Ougen, R Couderc and J C Agneray
    J Immunol February 15, 1987, 138 (4) 1157-1163;
  • You have accessRestricted access
    Anti-angiotensin II anti-idiotypic antibodies bind to angiotensin II receptor.
    P O Couraud
    J Immunol February 15, 1987, 138 (4) 1164-1168;
  • You have accessRestricted access
    Arsonate-specific murine T cell clones. IV. Properties of I-E- and I-A-restricted clones.
    J H Spragg and J W Goodman
    J Immunol February 15, 1987, 138 (4) 1169-1177;
  • You have accessRestricted access
    Association with beta 2-microglobulin controls the expression of transfected human class I genes.
    R S Rein, G H Seemann, J J Neefjes, F M Hochstenbach, N J Stam and H L Ploegh
    J Immunol February 15, 1987, 138 (4) 1178-1183;
  • You have accessRestricted access
    Recognition of human polymorphonuclear leukocyte receptors for leukotriene B4 by rabbit anti-idiotypic antibodies to a mouse monoclonal antileukotriene B4.
    L A Gifford, T Chernov-Rogan, J P Harvey, C H Koo, D W Goldman and E J Goetzl
    J Immunol February 15, 1987, 138 (4) 1184-1189;
  • You have accessRestricted access
    Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin.
    L Baud, J Perez, M Denis and R Ardaillou
    J Immunol February 15, 1987, 138 (4) 1190-1195;
  • You have accessRestricted access
    Biochemical characterization of a mast cell plasma membrane antigen shared by mouse serosal, culture-derived, and virally transformed mast cells.
    H R Katz and K F Austen
    J Immunol February 15, 1987, 138 (4) 1196-1200;
  • You have accessRestricted access
    Potentiation of PGE1-induced increase in cyclic AMP by chemotactic peptide and Ca2+ ionophore through calmodulin-dependent processes.
    J Ishitoya and T Takenawa
    J Immunol February 15, 1987, 138 (4) 1201-1207;
  • You have accessRestricted access
    A serine proteinase inhibitor produced by an HTLV I virus-transformed human T lymphocyte line.
    D Ganea, D Cearlock, J Minowada and S Dray
    J Immunol February 15, 1987, 138 (4) 1208-1214;
  • You have accessRestricted access
    Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    K L Fresa, H E Karjalainen and S S Tevethia
    J Immunol February 15, 1987, 138 (4) 1215-1220;
  • You have accessRestricted access
    Anti-T cell receptor antibodies fail to inhibit specific lysis by CTL clones but activate lytic activity for irrelevant targets.
    T J Henkel, V L Braciale and T J Braciale
    J Immunol February 15, 1987, 138 (4) 1221-1228;
  • You have accessRestricted access
    Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells.
    R Cauda, C E Grossi, R J Whitley and A B Tilden
    J Immunol February 15, 1987, 138 (4) 1229-1233;
  • You have accessRestricted access
    Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro.
    J F Sheridan, M Beck, C C Smith and L Aurelian
    J Immunol February 15, 1987, 138 (4) 1234-1239;
  • You have accessRestricted access
    Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro.
    A Hamada and B M Greene
    J Immunol February 15, 1987, 138 (4) 1240-1245;
  • You have accessRestricted access
    Macrophage activation for antileishmanial defense by an apparently novel mechanism.
    D J Wyler, D I Beller and J P Sypek
    J Immunol February 15, 1987, 138 (4) 1246-1249;
  • You have accessRestricted access
    Anaphylaxis-mediated epithelial Cl- secretion and parasite rejection in rat intestine.
    Y Harari, D A Russell and G A Castro
    J Immunol February 15, 1987, 138 (4) 1250-1255;
  • You have accessRestricted access
    Use of a DNA probe to measure the neutralization of Plasmodium berghei sporozoites by a monoclonal antibody.
    A Ferreira, T Morimoto, R Altszuler and V Nussenzweig
    J Immunol February 15, 1987, 138 (4) 1256-1259;
  • You have accessRestricted access
    T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level.
    J J van Dongen, T Quertermous, C R Bartram, D P Gold, I L Wolvers-Tettero, W M Comans-Bitter, H Hooijkaas, H J Adriaansen, A de Klein and A Raghavachar
    J Immunol February 15, 1987, 138 (4) 1260-1269;
  • You have accessRestricted access
    Spontaneous deletion at the B2m locus: evidence for site-specific genetic rearrangement.
    T A Potter, W Frankel, R A Zeff and T V Rajan
    J Immunol February 15, 1987, 138 (4) 1270-1274;
  • You have accessRestricted access
    Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines.
    P V Basta, P A Sherman and J P Ting
    J Immunol February 15, 1987, 138 (4) 1275-1280;
  • You have accessRestricted access
    Germ-line affinity and germ-line variable-region genes in the B cell response.
    M M Chua, S H Goodgal and F Karush
    J Immunol February 15, 1987, 138 (4) 1281-1288;
  • You have accessRestricted access
    Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
    M S Kaminski, K Kitamura, D G Maloney and R Levy
    J Immunol February 15, 1987, 138 (4) 1289-1296;
  • You have accessRestricted access
    Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
    S Ferrini, S Miescher, M R Zocchi, V von Fliedner and A Moretta
    J Immunol February 15, 1987, 138 (4) 1297-1302;
  • You have accessRestricted access
    The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    S Bara and T F Lint
    J Immunol February 15, 1987, 138 (4) 1303-1309;
  • You have accessRestricted access
    Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    M Tsujisaki, M Igarashi, K Sakaguchi, M Eisinger, M Herlyn and S Ferrone
    J Immunol February 15, 1987, 138 (4) 1310-1316;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 138, Issue 4
15 Feb 1987
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606